Meridian Wealth Partners, LLC Centessa Pharmaceuticals PLC Transaction History
Meridian Wealth Partners, LLC
- $685 Million
- Q2 2025
A detailed history of Meridian Wealth Partners, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Meridian Wealth Partners, LLC holds 38,101 shares of CNTA stock, worth $926,997. This represents 0.07% of its overall portfolio holdings.
Number of Shares
38,101Holding current value
$926,997% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
126Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$486 Million73.31% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$242 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$236 Million4.43% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.4MShares$204 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$159 Million0.04% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.3B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...